Association Between Exposure to Outdoor Artificial Light at Night and Sleep Disorders Among Children in China.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Original Publication: Chicago, IL : American Medical Association, [2018]-

Light Pollution* ; Sleep Wake Disorders*/epidemiology ; Sleep Wake Disorders*/etiology; Adolescent ; Child ; China/epidemiology ; Cross-Sectional Studies ; Humans ; Male ; Sleep

Importance: Healthy sleep has an important role in the physical and mental health of children. However, few studies have investigated the association between outdoor artificial light at night (ALAN) and sleep disorders in children.
Objective: To explore the associations between outdoor ALAN exposure and sleep disorders in children.
Design, Setting, and Participants: This population-based cross-sectional study, part of the National Chinese Children Health Study, was conducted from April 1, 2012, to June 30, 2013, in the first stage and from May 1, 2016, to May 31, 2018, in the second stage in 55 districts of 14 cities in China. This analysis included 201 994 children and adolescents aged 2 to 18 years. Data were analyzed from February 20 to March 21, 2022.
Exposures: Outdoor ALAN exposure (in nanowatts per centimeters squared per steradian) within 500 m of each participant's residential address obtained from the satellite imagery data, with a resolution of approximately 500 m.
Main Outcomes and Measures: Sleep disorders were measured by the Chinese version of the Sleep Disturbance Scale for Children. Generalized linear mixed models were used to estimate the associations of outdoor ALAN with sleep scores and sleep disorders.
Results: The study included 201 994 children and adolescents (mean [SD] age, 11.3 [3.2] years; 106 378 boys [52.7%]), 7166 (3.5%) of whom had sleep disorder symptoms. Outdoor ALAN exposure of study participants ranged from 0.02 to 113.48 nW/cm2/sr. Compared with the lowest quintile (Q1) of outdoor ALAN exposure, higher quintiles of exposure (Q2-Q5) were associated with an increase in total sleep scores of 0.81 (95% CI, 0.66-0.96) in Q2, 0.83 (95% CI, 0.68-0.97) in Q3, 0.62 (95% CI, 0.46-0.77) in Q4, and 0.53 (95% CI, 0.36-0.70) in Q5. Higher quintiles of exposure were also associated with odds ratios for sleep disorder of 1.34 (95% CI, 1.23-1.45) in Q2, 1.43 (95% CI, 1.32-1.55) in Q3, 1.31 (95% CI, 1.21-1.43) in Q4, and 1.25 (95% CI, 1.14-1.38) in Q5. Similar associations were observed for sleep disorder subtypes. In addition, greater effect estimates were found among children younger than 12 years.
Conclusions and Relevance: The findings of this cross-sectional study suggest that sleep disorders are more prevalent among children residing in areas with high levels of outdoor ALAN and the associations are generally stronger in children younger than 12 years. These findings further suggest that effective control of outdoor ALAN may be an important measure for improving the quality of children's sleep.

JAMA Psychiatry. 2020 Dec 1;77(12):1266-1275. (PMID: 32639562)
Sleep. 2016 Jun 01;39(6):1311-20. (PMID: 27091523)
Chronobiol Int. 2016;33(3):301-14. (PMID: 26950542)
Eur Heart J. 2021 Feb 21;42(8):822-830. (PMID: 33205210)
J Clin Endocrinol Metab. 2015 Nov;100(11):4067-73. (PMID: 26301944)
Int J Epidemiol. 2016 Dec 1;45(6):1887-1894. (PMID: 28089956)
Sleep Health. 2016 Sep;2(3):211-218. (PMID: 29073425)
Environ Health Perspect. 2019 Jun;127(6):67001. (PMID: 31157976)
Lancet Reg Health West Pac. 2021 May 13;11:100167. (PMID: 34327368)
Endocr Rev. 2016 Dec;37(6):584-608. (PMID: 27763782)
Pediatrics. 2010 Jun;125(6):e1410-8. (PMID: 20457689)
Chronobiol Int. 2012 May;29(4):502-8. (PMID: 22214237)
Chronobiol Int. 2021 May;38(5):638-658. (PMID: 33612016)
Tob Control. 2012 Jul;21(4):392-5. (PMID: 22246780)
Sci Total Environ. 2020 Nov 20;744:140914. (PMID: 32755781)
Sleep. 2009 Dec;32(12):1602-9. (PMID: 20041596)
Sleep Med. 2021 Jul;83:248-255. (PMID: 34049044)
J Allergy Clin Immunol Pract. 2013 May-Jun;1(3):214-26; quiz 227. (PMID: 24565478)
Sci Total Environ. 2017 Dec 31;607-608:1073-1084. (PMID: 28724246)
Sleep Med Rev. 2011 Oct;15(5):293-9. (PMID: 21316270)
Int J Obes (Lond). 2013 Apr;37(4):552-8. (PMID: 23419602)
Sleep Med. 2014 Aug;15(8):923-8. (PMID: 24916093)
Environ Res. 2020 Jan;180:108823. (PMID: 31627155)
Environ Res. 2021 May;196:110406. (PMID: 33130170)
Obesity (Silver Spring). 2020 Jul;28 Suppl 1:S18-S28. (PMID: 32700826)
J Epidemiol Community Health. 2018 Nov;72(11):1064-1070. (PMID: 29907705)
J Clin Endocrinol Metab. 2014 Sep;99(9):3298-303. (PMID: 24840814)
Sleep Health. 2017 Feb;3(1):6-19. (PMID: 28346153)
Am J Hum Biol. 2019 Nov;31(6):e23300. (PMID: 31342600)
Pediatr Res. 2019 Jun;85(7):936-942. (PMID: 30858473)
N Engl J Med. 2021 Feb 11;384(6):550-561. (PMID: 33567194)
J Sleep Res. 1996 Dec;5(4):251-61. (PMID: 9065877)
Sci Adv. 2016 Jun 10;2(6):e1600377. (PMID: 27386582)
Chronobiol Int. 2015;32(9):1294-310. (PMID: 26375320)
Curr Biol. 2016 May 23;26(10):R432-43. (PMID: 27218855)
Sleep Med Rev. 2014 Oct;18(5):393-7. (PMID: 24629825)
J Clin Sleep Med. 2018 Nov 15;14(11):1903-1910. (PMID: 30373695)
Sleep Med Rev. 2017 Feb;31:39-47. (PMID: 26899741)
Sleep Health. 2015 Mar;1(1):40-43. (PMID: 29073412)
Neurol Res. 2017 Jun;39(6):559-565. (PMID: 28460563)
Sleep. 2021 Feb 12;44(2):. (PMID: 33049062)
Environ Health Perspect. 2017 Aug 02;125(8):087003. (PMID: 28886599)

Date Created: 20220520 Date Completed: 20220524 Latest Revision: 20220716

20231215

PMC9123501

10.1001/jamanetworkopen.2022.13247

35594042